Advertisement
Legal
Subscribe to Legal

The Lead

Execution Drug Cost Quadruples for Texas Prisons

August 15, 2014 2:45 pm | by MICHAEL GRACZYK, Associated Press | News | Comments

The prison agency in the nation's busiest death penalty state paid $13,500 for its most recent batch of pentobarbital at a cost of $1,500 per vial, compared to $350 per dose spent last year.           

Turkish Man Pleads Guilty to Importing Illegal Cancer Drugs

August 15, 2014 2:41 pm | News | Comments

Sabahaddin Akman, owner of the Istanbul, Turkey, firm Ozay Pharmaceuticals, has pleaded guilty...

Judge Extends Temporary Halt to Ohio Executions

August 12, 2014 8:26 am | by ANDREW WELSH-HUGGINS, AP Legal Affairs Writer | News | Comments

A freeze on capital punishment in Ohio will continue into 2015 after a federal judge extended a...

Former State AG Testifies in ex-Va. Governor Trial

August 12, 2014 8:12 am | by LARRY O'DELL, Associated Press | News | Comments

The wealthy businessman who lavished former Virginia Gov. Bob McDonnell and his wife with...

View Sample

FREE Email Newsletter

McKesson Settles Tennessee Vaccine Case for $18M

August 11, 2014 8:29 am | News | Comments

McKesson Corp. was required to ensure vaccines were maintained at proper temperatures by, among other things, setting electronic temperature monitors to detect when air temperature in the box reached certain levels.      

AIDS Patients Fear Discrimination in ACA Exchange

August 7, 2014 8:47 am | by KELLI KENNEDY, Associated Press | News | Comments

Patient advocates say some insurance companies are making HIV and AIDS drugs unaffordable in plans issued through the Affordable Care Act by shifting much of the cost to customers. While the issue applies broadly to all patients with chronic illnesses that require expensive medication, HIV and AIDS advocates say they were the first to file a formal complaint with the government about pricing.

Mallinckrodt Settles OFIRMEV® Patent Litigation with Fresenius Kabi USA

August 7, 2014 8:40 am | News | Comments

Mallinckrodt today announced that its subsidiary, Cadence Pharmaceuticals, Inc., has entered into settlement and license agreements with Fresenius Kabi USA, LLC, resolving pending patent litigation involving OFIRMEV ® (acetaminophen) injection.

Advertisement

Pfizer to Pay $35M to Settle Drug Marketing Case

August 6, 2014 4:38 pm | by The Associated Press | News | Comments

Pfizer will pay $35 million to resolve allegations by 42 states that its subsidiary, Wyeth Pharmaceuticals, illegally marketed an organ transplant drug for unapproved uses. The states' attorneys general said Wednesday that Wyeth, which Pfizer bought in 2009, trained sales representatives to prescribe Rapamune for uses other than preventing rejection of transplanted kidneys.

China Probes Pharmaceutical Companies, Automakers, Technology Firms

August 6, 2014 8:13 am | by JOE McDONALD, AP Business Writer | News | Comments

Chinese regulators have launched a series of anti-monopoly investigations of foreign automakers and technology providers, stepping up pressure on foreign companies that feel increasingly unwelcome in China.        

Investigators Say Doctor Prescribed Painkillers for Profit

August 4, 2014 9:09 am | Videos | Comments

Federal investigators warn of the growing problem of "dirty doctors," who prescribe highly-addictive painkillers for cash.                      

Allergan Sues Valeant, Claims Fraud in Buy Attempt

August 1, 2014 3:34 pm | by Linda A. Johnson - AP Business Writer - Associated Press | News | Comments

Allergan Inc.'s lawsuit, filed Friday in U.S. District Court in Santa Ana, California, names as plaintiffs drugmaker Valeant Pharmaceuticals International Inc., New York investment and hedge fund firm Pershing Square Capital Management LP and its principal, William Ackerman.

Former Virgina Governor Back in Court

July 31, 2014 11:07 am | Videos | Comments

Bob McDonnell headed back to court Thursday over federal corruption charges alleging that he and his wife accepted more than $165,000 in gifts, lavish trips, and cash in exchange for promoting dietary supplements.                 

Advertisement

Idaho Officials: Prison Takeover Reveals Lack of Inmate Medications

July 29, 2014 8:44 am | by REBECCA BOONE, Associated Press | News | Comments

Idaho prison officials say they had to have thousands of dollars' worth of medications shipped overnight to the state's largest prison after the former operator, Corrections Corporation of America, left the facility without a promised eight-day supply of inmate drugs.

China to Put Glaxo Investigators On Trial

July 29, 2014 5:30 am | by The Associated Press | News | Comments

A Shanghai court says American and British investigators who worked for drug maker GlaxoSmithKline will stand trial Aug. 8 on charges of illegally obtaining information on Chinese citizens. The Shanghai No. 1 Intermediate People's Court said Tuesday that Yingzeng Yu and her husband Peter Humphrey will have a "public trial."

Arizona Execution Renews Debate Over Methods

July 28, 2014 8:14 am | by PAUL ELIAS, Associated Press | News | Comments

A third execution by lethal injection has gone awry in six months, renewing debate over whether there is a foolproof way for the government to humanely kill condemned criminals, and whether it's even worth looking for one.     

Obama Wants Limits on US Company Mergers Abroad

July 25, 2014 8:32 am | News | Comments

Staking out a populist stand ahead of the midterm elections, President Barack Obama on Thursday demanded "economic patriotism" from U.S. corporations that use legal means to avoid U.S. taxes through overseas mergers.      

When Will We Learn?

July 23, 2014 3:11 pm | by Mike Auerbach, Editor In Chief | Blogs | Comments

Humans are a strange lot. We are more than willing to believe just about any product claim in the hopes that an easy solution to our problem can be found inside a pill, tablet or liquid.           

Advertisement

States Sue 5-Hour Energy Over Ad Claims

July 21, 2014 8:35 am | by STEVEN DUBOIS, Associated Press | News | Comments

The Oregon lawsuit filed Thursday in Portland contends 5-Hour Energy falsely claims customers get extra energy and focus from a unique blend of ingredients, when the boost actually comes from a concentrated dose of caffeine.     

China Indicts US, British Nationals Involved In GSK Investigation

July 13, 2014 11:26 pm | by The Associated Press | News | Comments

Chinese authorities formally indicted two corporate investigators, an American and Briton, for allegedly illegally obtaining and selling private information, state media reported Monday. Prosecutors in Shanghai filed charges against British investigator Peter Humphrey and his wife Yingzeng Yu, a U.S. citizen, at the city's No. 1 Intermediate People's Court, the official Xinhua News Agency said.

Compounding Pharmacy Oversight Changes Signed

July 11, 2014 8:22 am | News | Comments

Two years after a deadly nationwide meningitis outbreak linked to a compounding pharmacy in Massachusetts, Gov. Deval Patrick on Thursday signed a law he said would address a "gray area" between state and federal oversight of the pharmacies.  

Neurelis Regains Rights to Intranasal Diazepam Program

July 11, 2014 8:08 am | News | Comments

Neurelis has announced an agreement with Biotie Therapies to end the option held by Biotie to purchase Neurelis, clearing the way for Neurelis to commence further development of NRL-1 for pediatric and adult epilepsy patients who experience acute repetitive seizures.

Hospital Pharmacist Charged in Theft of 200K Pills

July 9, 2014 8:19 am | by JENNIFER PELTZ, Associated Press | News | Comments

A pharmacist who oversaw a major hospital's vault of drugs stole nearly 200,000 powerful painkillers he was supposed to safeguard and dispense, narcotics prosecutors said Tuesday as they unveiled a case that makes unusual use of a state drug-kingpin law.

$580M EU Antitrust Fine for Drug Makers

July 9, 2014 8:14 am | News | Comments

The European Union's antitrust body is imposing a fine of 428 million euros ($580 million) on France's pharmaceutical company Servier and five producers of generic medicines for distorting competition.        

US Officials Barred from American's Trial in China

July 4, 2014 5:25 am | by The Associated Press | News | Comments

A U.S. Embassy spokesman says diplomats are barred from the trial in Shanghai of an American investigator for GlaxoSmithKline and her British husband who are charged with improperly selling personal information. Spokesman Nolan Barkhouse said Friday that the U.S. government is concerned about lack of access to the trial of Yu Yingzeng and husband Peter Humphrey in August.

AIDS Scientist Pleads Not Guilty to Faking Study

July 2, 2014 8:22 am | by DAVID PITT, Associated Press | News | Comments

Dong-Pyou Han, 57, entered his not guilty pleas to four counts of making false statements during his initial court appearance in Des Moines federal court. Each count carries a maximum sentence of five years in prison and a $250,000 fine.  

Justices: Can't Make Employers Cover Contraception

June 30, 2014 2:08 pm | by MARK SHERMAN, Associated Press | News | Comments

The Supreme Court ruled Monday that some corporations can hold religious objections that allow them to opt out of the new health law requirement that they cover contraceptives for women. The justices' 5-4 decision is the first time that the high court has ruled that profit-seeking businesses can hold religious views under federal law.

High Court Poised to Decide Birth-Control Dispute

June 30, 2014 8:17 am | by MARK SHERMAN, Associated Press | News | Comments

The Supreme Court is poised to deliver its verdict in a case that weighs the religious rights of employers and the right of women to the birth control of their choice. The court meets for a final time Monday to release decisions in its two remaining cases before the justices take off for the summer.

Actavis Confirms Generic Zubsolv Patent Challenge

June 30, 2014 8:00 am | News | Comments

Actavis' ANDA product is a generic version of Orexo's Zubsolv, which is a partial opioid agonist indicated for the maintenance treatment of opioid dependence.               

Pershing Square Settles Lawsuit with Allergan

June 27, 2014 3:28 pm | by The Associated Press | News | Comments

Pershing Square, the investment firm run by activist investor Bill Ackman, said Friday it settled a lawsuit with Allergan, the maker of Botox, related to Allergan's poison pill plan and Pershing's $53 billion offer for the company.   

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading